Patient selection and predicting response to recombinant human erythropoietin in anemic cancer patients

Seminars in Hematology

Volumn 33, Issue 1 SUPPL. 1, 1996, Pages 2-5

  Henry III, D H ^a   Thatcher, N ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CANCER PATIENT; CLINICAL TRIAL; DRUG RESPONSE; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; RETICULOCYTE COUNT; REVIEW; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANEMIA; EPOETIN ALFA; HUMANS; NEOPLASMS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 0030066113     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)